Basic Information (Switzerland) Elecon Asia SA (hereinafter referred to as “Elecon”) is a powerful intelligent three-d...
Digital Copyright Ten Major Typical Cases 1.Short Video Copyright Case: Whether a Short Video is Original Has Nothing to...
December 7, 2023 - News of a patent infringement ruling against Apple Watches a few weeks ago caused a flurry of investo...
patent holder Regeneron, the drug achieved global sales of around $9 billion in 2023. Bayer and Regeneron are fighting hard to retain market exclusivity. The dispute spans numerous European countries
CosMX has been ordered to pay RMB 9.9 million in damages to its rival Amperex Technology Limited (ATL) in a patent infringement case, as per a recent ruling by the Fujian High People’s Court. The
victory for patent holder InterDigital that could open a new chapter in telecommunications patent disputes. Until now, implementers have often avoided patent infringement claims by applying to UK
Patent holder Nokia is extending its litigation campaign against Paramount to Europe. Following lawsuits in the US and Brazil, the Finnish company has now filed further infringement proceedings at
Edwards Lifesciences has secured an important victory before the Unified Patent Court in its long-running heart valve dispute. The Nordic-Baltic division confirmed the patent in amended form and
Patent litigation history and searches reveal significant validity divergence within Xu Wei's QR code patent portfolio. Corn patents (e.g., ZL201210113851.8) have survived multiple invalidation
Context: Japanese courts have long stayed out of standard-essential patent (SEP) enforcement discussions – notably since a 2014 Apple v. Samsung IP High Court Grand Panel decision affirmed that while
towards amicable resolutions, even in complex, multi-jurisdictional patent disputes. A significant number of UPC disputes have concluded with a settlement since the start of the year. Following Roche’s
Generic drug companies cannot launch their enzalutamide products in the Netherlands. In the pan-European dispute over prostate cancer drug Xtandi, the District Court The Hague upheld a basic patent
The global patent disputes between mRNA vaccine manufacturers have once again set the patent community buzzing. While GSK launched several lawsuits at the UPC against Moderna, BioNTech and Pfizer in
CHINA intellectual PROPERTY LAWYERS NETWORK
+86-13910160652
ciplawyers@163.com
